MKI67 and leiomyosarcoma: According to the AIOM guidelines of 2019 (updated in October 2019), evaluation of the expression of the progesterone receptor (PgR), p53, and Ki67 could help pathologists in the differential diagnosis between leiomyosarcoma, leiomyoma and STUMPs.